Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1975 1
1982 1
1984 1
1986 1
1987 1
1988 1
1989 1
1990 1
1991 2
1993 1
1994 1
1995 3
1996 5
1997 1
1998 1
1999 2
2000 1
2003 5
2004 3
2006 2
2007 6
2008 2
2009 1
2011 2
2012 1
2013 3
2014 3
2015 4
2016 6
2017 6
2018 3
2019 2
2020 3
2021 2
2022 2
2023 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

77 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Glanzmann thrombasthenia 2"
Page 1
Inherited bleeding disorders.
Blanchette VS, Sparling C, Turner C. Blanchette VS, et al. Baillieres Clin Haematol. 1991 Apr;4(2):291-332. doi: 10.1016/s0950-3536(05)80162-3. Baillieres Clin Haematol. 1991. PMID: 1912663 Review.
Second, in occasional patients the inherited disorder is complex and reflects combined abnormalities of coagulation proteins alone or in association with platelet disorders. In clinical practice it is useful to distinguish disorders that cause significant clinical b …
Second, in occasional patients the inherited disorder is complex and reflects combined abnormalities of coagulation proteins alone or in ass …
New Insights Into the Treatment of Glanzmann Thrombasthenia.
Poon MC, Di Minno G, d'Oiron R, Zotz R. Poon MC, et al. Transfus Med Rev. 2016 Apr;30(2):92-9. doi: 10.1016/j.tmrv.2016.01.001. Epub 2016 Jan 30. Transfus Med Rev. 2016. PMID: 26968829 Free article. Review.
Glanzmann thrombasthenia (GT) is a rare inherited autosomal recessive bleeding disorder of platelet function caused by a quantitative or qualitative defect of platelet membrane glycoprotein IIb/IIIa (integrin alphaIIbbeta3), a fibrinogen receptor required for platel …
Glanzmann thrombasthenia (GT) is a rare inherited autosomal recessive bleeding disorder of platelet function caused by a quant …
Anti-alpha(IIb) beta(3) immunization in Glanzmann thrombasthenia: review of literature and treatment recommendations.
Fiore M, d'Oiron R, Pillois X, Alessi MC. Fiore M, et al. Br J Haematol. 2018 Apr;181(2):173-182. doi: 10.1111/bjh.15087. Epub 2018 Apr 2. Br J Haematol. 2018. PMID: 29611179 Free article. Review.
Glanzmann thrombasthenia (GT) is caused by inherited defects of the alpha(II)(b) beta(3) platelet glycoprotein. ...This review will summarize the current knowledge of the risk factors for development of anti-alpha(II)(b) beta(3) antibodies in patients with GT and di …
Glanzmann thrombasthenia (GT) is caused by inherited defects of the alpha(II)(b) beta(3) platelet glycoprotein. ...This review …
Eptacog alfa activated: a recombinant product to treat rare congenital bleeding disorders.
Di Minno G. Di Minno G. Blood Rev. 2015 Jun;29 Suppl 1:S26-33. doi: 10.1016/S0268-960X(15)30005-9. Blood Rev. 2015. PMID: 26073366 Review.
Glanzmann's thrombasthenia (GT) and congenital factor VII deficiency (FVII CD) are rare autosomal recessive bleeding disorders: GT is the most frequent congenital platelet function disorder, and FVII CD is the most common factor-deficiency disease after haemophilia. …
Glanzmann's thrombasthenia (GT) and congenital factor VII deficiency (FVII CD) are rare autosomal recessive bleeding disorders …
The Judicious Use of Recombinant Factor VIIa.
Goodnough LT, Levy JH. Goodnough LT, et al. Semin Thromb Hemost. 2016 Mar;42(2):125-32. doi: 10.1055/s-0035-1569068. Epub 2016 Feb 2. Semin Thromb Hemost. 2016. PMID: 26838698 Review.
Recombinant activated factor VIIa (rFVIIa) is a prohemostatic agent initially approved for use in hemophilia patients with inhibitors and recently for Glanzmann thrombasthenia. Despite its approval indications, rFVIIa has also been used for a diverse range of off-la …
Recombinant activated factor VIIa (rFVIIa) is a prohemostatic agent initially approved for use in hemophilia patients with inhibitors and re …
Iron deficiency anemia and bleeding management in pediatric patients with Bernard-Soulier syndrome and Glanzmann Thrombasthenia: A single-institution analysis.
Lee A, Maier CL, Batsuli G. Lee A, et al. Haemophilia. 2022 Jul;28(4):633-641. doi: 10.1111/hae.14559. Epub 2022 Apr 12. Haemophilia. 2022. PMID: 35412688 Free PMC article.
INTRODUCTION: Frequent and severe bleeding events (SBE) in patients with inherited qualitative platelet disorders Bernard-Soulier Syndrome (BSS) and Glanzmann Thrombasthenia (GT) can lead to secondary iron deficiency anemia (IDA). ...Following initiation of rFVIIa p …
INTRODUCTION: Frequent and severe bleeding events (SBE) in patients with inherited qualitative platelet disorders Bernard-Soulier Syndrome ( …
Recombinant activated factor VII in clinical practice: a 2014 update.
Franchini M, Crestani S, Frattini F, Sissa C, Bonfanti C. Franchini M, et al. J Thromb Thrombolysis. 2015 Feb;39(2):235-40. doi: 10.1007/s11239-014-1114-1. J Thromb Thrombolysis. 2015. PMID: 25015059 Review.
Recombinant activated factor VII (rFVIIa) was initially developed to treat bleeding episodes in patients with congenital hemophilia and inhibitors. Due to the initial success in this clinical setting, its use has been extended to other coagulopathies characterized by impai …
Recombinant activated factor VII (rFVIIa) was initially developed to treat bleeding episodes in patients with congenital hemophilia and inhi …
Inherited platelet disorders and oral health.
Valera MC, Kemoun P, Cousty S, Sie P, Payrastre B. Valera MC, et al. J Oral Pathol Med. 2013 Feb;42(2):115-24. doi: 10.1111/j.1600-0714.2012.01151.x. Epub 2012 May 15. J Oral Pathol Med. 2013. PMID: 22583386 Review.
The defects can reflect deficiency or dysfunction of platelet surface glycoproteins, granule contents, cytoskeletal proteins, platelet pro-coagulant function, and signaling pathways. For instance, Bernard-Soulier syndrome and Glanzmann thrombasthenia are attributed …
The defects can reflect deficiency or dysfunction of platelet surface glycoproteins, granule contents, cytoskeletal proteins, platelet pro-c …
Surgical procedures in patients with Glanzmann's thrombasthenia: case series and literature review.
Ganapule A, Jain P, Abubacker FN, Korula A, Abraham A, Mammen J, George B, Mathews V, Srivastava A, Viswabandya A. Ganapule A, et al. Blood Coagul Fibrinolysis. 2017 Mar;28(2):171-175. doi: 10.1097/MBC.0000000000000524. Blood Coagul Fibrinolysis. 2017. PMID: 27273143 Review.
Glanzmann's thrombasthenia is a rare platelet function disorder with an autosomal recessive pattern of inheritance. Achieving haemostasis in such patients who undergo surgical procedures always poses a significant challenge. Herein we report six cases of Glanzman …
Glanzmann's thrombasthenia is a rare platelet function disorder with an autosomal recessive pattern of inheritance. Achieving …
A Successful Renal Transplant in a Pediatric Patient With Glanzmann Thrombasthenia and Hyperimmunization.
Bastard P, Couderc A, Kwon T, Hogan J, Niel O, Cambier A, Ali L, Smaine D, Maisin A, Deschenes G, Hurtaud MF, Macher MA. Bastard P, et al. Exp Clin Transplant. 2019 Dec;17(6):831-834. doi: 10.6002/ect.2019.0174. Epub 2019 Oct 1. Exp Clin Transplant. 2019. PMID: 31580240 Free article.
We report the case of a patient with type 2 Glanzmann thrombasthenia who underwent successful kidney transplant with his mother's kidney. He started dialysis at 13 months. The patient had been diagnosed with Glanzmann thrombasthenia at 9 years o …
We report the case of a patient with type 2 Glanzmann thrombasthenia who underwent successful kidney transplant with hi …
77 results